Stability-Specific HPLC Analysis of the Antiulcer Prostaglandin,Enprostil, in a Soft Elastic Gelatin Capsule Formulation

Abstract

This report describes a reverse-phase HPLC assay for the antiulcer drug, enprostil, formulated as a 0.3 mM solution (in propylene carbonate) filled into soft elastic gelatin capsules. The method uses: a 5 μm C18 column, a ternary (THF-methanol-phosphate buffer) mobile phase and 220 nm spectrophotometric detection to provide a sensitive and specific assay for enprostil and its major degradation products. The method satisfies the usual statistical criteria (recovery efficiency, response linearity, precision, lower quantitation limit) and performs well under various operating conditions as demonstrated by system suitability tests (analyte capacity factor dependence on column type, mobile phase composition, flow rate, and column temperature). We also demonstrate how a diode-array spectrophotometric detector     

Separation of the stereoisomers of an allenic E-type prostaglandin

Enprostil (I) is a synthetic dehydro-prostaglandin E2 containing a chiral allene moiety which is unresolved relative to the four remaining chiral centers. The relative configuration of the four remaining chiral centers is consistent with that of the naturally occurring E series of prostaglandins. Thus, enprostil exists as enantiomeric pairs of two allenic epimers. An analytical procedure has been developed that separates the four optical isomers present in enprostil. This procedure involves, first, the acid-catalyzed dehydration of enprostil to its corresponding prostaglandin A analogue followed by derivatization with beta-naphthylsulfonyl-L-prolyl chloride. The resulting diastereomeric sulfonate esters are separated on an achiral silica gel high-performance liquid chromatographic column. This procedure has been applied to the analysis of both enprostil drug substance and enprostil formulated in a propylene carbonate solution from soft elastic gelatin capsules. An efficient procedure for the recovery of enprostil from the solution formulation is also described.     

The Determination of Optical Isomers of 2-[3-(2-Chloro-Penoxyphenyl)]-Propionic Acid in Rat Plasma by High Performance Liquid Chromatography

Abstract

The optical isomers of dl-2-[3-(2-chlorophenoxy-phenyl)]-propionic acid in rat plasma is converted to the diastereomeric derivatives with (+)-2-aminobutane and then determined by high performance liquid chromatography using a Nucleosil NH₂ (10 μm) column and cyclohexane-ethyl acetate (5:1) as a mobile phase.

The time course of the optical isomers of this drug in rat plasma after oral administration was measured.

The proposed method is specific and reproducible for the determination of the optical isomers of this drug.     

Separation of D- and L-DOPA as their L-leucine derivatives by reversed-phase HPLC

Summary The separation and quantitation of D-DOPA as an impurity in L-DOPA is described. The method involves formation of the diastereomeric derivatives of DOPA with tert-butoxycarbonyl-L-leucine hydroxysuccinimide ester. Separation of the diastereomers was performed by reversed-phase liquid chromatography on LiChrosorb RP-18 and acetonitrile-phosphate buffer with addition of N,N-dimethyloctylamine as the mobile phase. The reproducibility of the method was 5.9% (relative standard deviation) at D-DOPA levels of 0.5% in L-DOPA drug substance.     

LC Method for Studies on the Stability of Lopinavir and Ritonavir in Soft Gelatin Capsules

This study describes the development and full validation of a stability-indicating HPLC method to quantify ritonavir (RTV) and lopinavir (LPV) in soft gelatin capsules. The method uses a LiChrospher^® 100 RP-18 (250 mm × 4.6 mm, 5 µm, Merck) column and isocratic elution. The mobile phase consisted of a mixture of acetonitrile-water-methanol (53:37:10, v/v/v), pumped at a flow-rate of 1.0 mL min^?1 and UV detection at 210 nm using a photodiode array detector. LPV and RTV were exposed to thermal, photolytic, hydrolytic and oxidative stress conditions, and the stressed samples were analyzed by the proposed method. The response was linear over a range of 40-360 µg mL^?1 for LPV and 10–90 µg mL^?1 for RTV (r > 0,999 for both drugs). The mean recoveries were 99.46 and 100.81% for LPV and RTV, respectively. The RSD values for intra- and inter-day precision studies were < 0.70% for both drugs. Degradation studies showed that lopinavir is stable in thermal, alkaline and oxidative conditions, while ritonavir degraded under these conditions. The method was found to be stability-indicating and can be used for the routine analysis of the association LPV/RTV in soft gelatin capsules.     

15N NMR spectroscopy 12:—steric effects in diastereomeric oligopeptides of alanine,phenylalanine and valine

Eight pairs of diastereomeric di-, tri-, and tetrapeptides were prepared from alamine, phenylalanine, valine and glycine. Their natural abundance ¹⁵N NMR spectra were measured in a 1:1 mixture of acetone/dimethyl sulphoxide and in all eight cases the diastereomers could be distinguished without the aid of shift reagents. The shift difference between the signals of diastereomers is dependent on the nature of the amino acid and on the solvent.     

Direct determination of the racemate ratio of labetalol hydrochloride by HPLC

Summary A direct, isocratic, reversed phase HPLC procedure is developed for the separation of the diastereomeric racemates of labetalol, a combined α- and β-adrenoreceptor antagonist. The aminoalcohol-type diastereomers were resolved on a C₁₈ column using methanolwater-25% ammonia 27-75-2 mobile phase and detection at 220nm. The procedure is simple and convenient to carry out. The method may be of use in the determination of the individual diastereomeric racemates of labetalol in different forms such as bulk substance, pharmaceutical dosage preparations and biological fluids. Presented at the 17th International Symposium on Chromatography, September 25–30, Vienna, Austria.     

THE ASSIGNMENT OF ACYCLIC STEREOISOMERS. 11. CONFORMATIONAL ANALYSIS OF 3-PHOSPHONYL-2- BENZOYLAMINOPROPIONIC ACID METHYL-ESTERS

Abstract

The conformational analysis of 3-phosphonyl-2-benzoylaminopropionic acid methyl esters, which occur as diastereomeric pairs of enantiomers owing to two present chiral centres, has been managed successfully by means of ³¹P, ¹³C, ¹H and ¹⁵N chemical shifts as well as the characteristically different coupling constants between the ¹H, ¹³C and ³¹P nuclei. In this light, the diastereomers involved could be assigned readily.     

RP-HPLC拆分普萘洛尔对映体的洗脱顺序及其荧光响应研究

应用反相高效液相色谱法,以（Ｒ,Ｒ）－Ｏ,Ｏ－二乙酰基酒石酸酐（ＤＡＴＡＡＮ）为手性衍生化试剂,拆分了普萘洛尔（ｐｒｏｐｒａｎｏｌｏｌ）对映体。实验结果显示：普萘洛尔对映体经衍生化而生成的两个非对映异构体分子的空间结构有着明显的差异,即（Ｒ,Ｒ,Ｒ）－异构体中存在着分子内氢键,而（Ｒ,Ｒ,Ｓ）－异构体中却没有,这种结构上的区别不仅成为控制洗脱顺序的主要因素,而且对其荧光响应也产生重要的影响。     

Study of “Racemic Compound-Like” Behavior of Diastereomeric Mixture of Pinanyl Sulfoxides by X-Ray Diffraction,IR Spectroscopy,and DFT Calculations

Abstract

The oxidation of a β-hydroxysulfide in the pinane series by use of m-chloroperbenzoic acid resulted in the formation of the corresponding β-hydroxysulfoxide as a mixture of two diastereomers in 4:5 ratio. According to single-crystal X-ray diffraction (XRD) results, it is established that the diastereomeric mixture of sulfoxides crystallizes in the “racemic compound-like” manner under formation of asymmetric dimers through S=O··H–O interactions. This asymmetric dimer formed from diastereomeric molecules is a structural unit in both crystal modifications, the triclinic and the monoclinic one. The behavior of the diastereomeric mixture of pinane derived sulfoxides in crystals, melts and in tetrachloromethane solutions was studied by IR spectroscopy. The density functional theory (DFT) method with 6-31G (d, p) basis set was used to calculate the optimized geometrical parameters and vibrational frequencies of different associates in solutions. The calculated vibrational frequencies are compared with experimental IR spectra.     

UV-Derivative Spectrophotometric Determination of Ritonavir Capsules and Comparison with LC Method

Abstract

An ultraviolet-derivative spectrophotometric method (UV-D) has been proposed as an alternative to a previously described liquid chromatographic (LC) method for the quantitative determination of ritonavir in soft gelatin capsules. The spectrophotometric method is based on recording the second-derivative spectra for ritonavir at 222.3 nm of its solutions in methanol. The linear dynamic range was 10.0–30.0 µg · mL^?1 with a correlation coefficient of 0.9995. Mean recoveries were between 99.2% and 100.2% for the tested capsules samples. Mean intra- and interassay relative standard deviations (RSDs) were less than 2.0%. The statistic analysis showed that LC and UV-D methods were equivalent to assay ritonavir capsules.     

Liquid-solid chromatography of diastereomers: Tetrasubstituted ethanes

Summary The separation by thin-layer chromatography (TLC) is reviewed for 25 pairs of tetrasubstituted-ethane diastereomers on silica. A total of 50 different mobile phases were used in order to define the basis of solvent selectivity for these separations. Separation factors (α) for various diastereomeric pairs are determined mainly by the relative localization of the strong solvent in these binary-solvent mobile phases (as measured by the mobile-phase parameter m). Relative retention of the diastereomers expressed by positive vs. negative values of α appear understandable on the basis of steric hindrance to adsorption and solvent-solute localization. Presented at the 15th International Symposium on Chromatography, Nürnberg, October 1984     

Validated Enantioselective LC Method, with Precolumn Derivatization with Marfey’s Reagent, for Analysis of the Antiepileptic Drug Pregabalin in Bulk Drug Samples

An enantioselective high-performance liquid chromatographic method, with precolumn derivatization with Marfey’s chiral reagent, sodium 2,4-dinitro-5-fluorophenyl-l-alanine amide, has been developed for resolution of the enantiomers of a new antiepileptic drug, pregabalin, in the bulk drug. The diastereomers of the pregabalin enantiomers were resolved to baseline on a reversed-phase ODS column with a 60:40 (v/v) mixture of aqueous 0.2% triethylamine (pH adjusted to 3.5 with dilute orthophosphoric acid) and acetonitrile as mobile phase. Resolution between the diastereomers was not less than five. The method was extensively validated and proved to be robust. The calibration plot was indicative of an excellent linear relationship between response and concentration over the range 750 (LOQ) to 7,500 ng L⁻¹ for the R enantiomer. The limits of detection and quantification of the R enantiomer were 250 and 750 ng L⁻¹, respectively, for an injection volume of 10 μL. Recovery of the R enantiomer from bulk drug samples of pregabalin ranged from 97.5 to 101.76%. Solutions of pregabalin in water and in the mobile phase were found to be stable for at least 48 h. The method was found to be suitable and accurate for quantitative determination of the R enantiomer in the bulk drug. It can be also used to test the stability of samples of pregabalin.     

LC Enantioseparation of 30-Component Diastereomeric Mixture of Amino Acids and Detection of d-Isomers Using New Reagents with Amines as Chiral Auxiliaries in Cyanuric Chloride

Two enantiomerically pure amines, viz., (R)-(+)-naphthylethyl amine and (S)-(+)-1-benzyl-3-aminopyrrolidine, were used as chiral auxiliaries for nucleophilic substitution of chlorine atoms in cyanuric chloride or its 6-butoxy derivative. The chiral derivatizing reagents so obtained were characterized and their chiral purity was ascertained. Diastereomers of 15 dl-proteinogenic amino acids were synthesized under microwave irradiation using these reagents. Separation of diastereomeric pairs along with separation of a mixture of 30 diastereomers in a single chromatographic run was carried out on a reversed-phase C₁₈ column. Mixtures of acetonitrile with aqueous trifluoroacetic acid were used as mobile phase. The detection was made at 230 nm using photo diode array detector. The separation behavior in terms of retention times and resolutions was compared on the basis of effect of chiral auxiliaries (i.e. amines) and achiral substituents (i.e. chlorine or butoxy group) in the chiral derivatizing reagents and the hydrophobic side chains of amino acids. The separation method was validated in terms of accuracy, precision, linearity, recovery, limit of detection and limit of quantitation. The method was successful for determination of d-amino acids in the absence of pure d-enantiomers and for separation of 19 diastereomers from a mixture of 30.     

LC Determination of Ritonavir, a HIV Protease Inhibitor, in Soft Gelatin Capsules

A rapid, simple and sensitive high-performance liquid chromatographic method (HPLC) has been developed to assay ritonavir in semisolid capsules. The HPLC analysis used a reversed-phase C₈ (125 × 4.0 mm i.d., 5 μm particle size) analytical column and a mobile phase consisting of methanol and water (67:33, v/v), with UV detection at 210 nm. Specificity was evaluated using a photodiode array detector (PDA). The validation data showed that the assay is sensitive, specific and reproducible for determination of ritonavir in this dosage form. Calibration curves were linear from 100–300 μm L^?1 (R² ≥ 0.999). The accuracy of the method ranged from 98.8 to 102.0%. Mean inter- and intra-assay relative standard deviations (RSD) were less than 1.0%. The proposed method provided an accurate and precise analysis of ritonavir in soft capsules, requiring neither the use of a buffered mobile phase, nor the addition of amine modifiers.     

Development of a Standardized Analysis Strategy for Basic Drugs,Using Ion-Pair Extraction and High-Performance Liquid Chromatography PART IV. Application to Solid Pharmaceutical Dosage Forms

Abstract

The usefulness of two standardized HPLC-systems for the analysis of basic drugs in tablets and capsules is exemplified. The standardized HPLC systems both use a CN-column combined with either a polar or a non polar mobile phase. Also the sample preparationis standardized and simple; it involves suspension of the powder mixture in one of the mobile phase components, centrifugation and injection of the clear supernatant.     

A novel approach for enantioseparation as applied to (RS)‐etodolac from pharmaceutical formulations: LC MS and density functional theory support for confirmation of diastereomers so separated

In the present studies formation of diastereomers of (RS)‐etodolac was confirmed using LC‐MS when [M + H]⁺ or [M]⁺ were recorded for the diastereomers. The lowest energy optimized structures of two diastereomers were drawn, which confirmed the three‐dimensional geometry of the diastereomers. This supports the optimized analytical separation conditions. In addition, separation of diastereomers was successful using a C₁₈ column and a binary mixture of methanol and triethyl ammonium phosphate buffer of pH 4.5 (80:20, v/v) as mobile phase at a flow rate of 1 mL min^?1 and UV detection at 223 nm. The separation method was validated as per International Conference on Harmonization guidelines. (RS)‐Etodolac was isolated from commercial tablets and purified and characterized to be used as racemic standard. Three pairs of diastereomers were synthesized using enantiomerically pure amines, namely, (R)‐(+)‐α‐methyl benzyl amine, (S)‐(?)‐α,4‐dimethylbenzylamine and (R)‐(?)‐1‐cyclohexylethylamine. Derivatization reactions were carried out under conditions of stirring at room temperature (30 °C for 2 h) as well as under microwave irradiation (MWI), and the two types of diastereomers were compared. Reaction conditions for derivatization were optimized with respect to mole ratio of chiral derivatizing agent and (RS)‐etodolac and MWI time. No racemization was observed throughout the study. Copyright © 2015 John Wiley & Sons, Ltd.     

Preparation and Characterization of Phospha Sugar Analogues, 2,3-Dibromo-3-methyl-1- phenylphospholane 1-Oxide Derivatives,as Novel Anticancer Agents

The synthesis of new phospha sugar analogues or phosphorus heterocycles and their biological activities as novel anticancer agents are reported in this article. A 1,2-dibromo-1,2-dideoxy phospha sugar derivative, 2,3-dibromo-3-methyl-1-phenylphospholane 1-oxide (2), was prepared from 1-phenyl-3-methyl-2-phospholene 1-oxide (1), and the yield and ratio of diastereomers 2a to 2d were changed by a catalyst such as manganese(IV) oxide and manganese(II) bromide. The antitumor activities of the mixture of dibromides 2 and the separated diastereomeric components 2a to 2d of the dibromides were evaluated by MTT in vitro method against the human leukemia cell lines of K562 and U937. The results showed that all of the diastereomers 2a to 2d as well as the diastereomer mixture exert excellent anticancer activity, and moreover, among them, diastereomer 2d showed the highest antitumor activity.

Supplemental materials are available for this article. Go to the publisher's online edition of Phosphorus, Sulfur, and Silicon and the Related Elements to view the free supplemental file.     

HPLC enantioseparation of racemic bupropion,baclofen and etodolac: modification of conventional ligand exchange approach by pre‐column formation of chiral ligand exchange complexes

Separation of racemic mixture of (RS)‐bupropion, (RS)‐baclofen and (RS)‐etodolac, commonly marketed racemic drugs, has been achieved by modifying the conventional ligand exchange approach. The Cu(II) complexes were first prepared with a few l ‐amino acids, namely, l ‐proline, l ‐histidine, l ‐phenylalanine and l ‐tryptophan, and to these was introduced a mixture of the enantiomer pair of (RS)‐bupropion, or (RS)‐baclofen or (RS)‐etodolac. As a result, formation of a pair of diastereomeric complexes occurred by ‘chiral ligand exchange’ via the competition between the chelating l ‐amino acid and each of the two enantiomers from a given pair. The diastereomeric mixture formed in the pre‐column process was loaded onto HPLC column. Thus, both the phases during chromatographic separation process were achiral (i.e. neither the stationary phase had any chiral structural feature of its own nor did the mobile phase have any chiral additive). Separation of diastereomers was successful using a C₁₈ column and a binary mixture of MeCN and TEAP buffer of pH 4.0 (60:40, v/v) as mobile phase at a flow rate of 1 mL/min and UV detection at 230 nm for (RS)‐Bup, 220 nm for (RS)‐Bac and 223 nm for (RS)‐Etd. Baseline separation of the two enantiomers was obtained with a resolution of 6.63 in <15 min. Copyright © 2016 John Wiley & Sons, Ltd.     

Synthesis of Valganciclovir Hydrochloride Congeners

Valganciclovir hydrochloride (1) is used for the treatment of cytomegalovirus (CMV) retinitis in patients with weakened immune systems. Valganciclovir hydrochloride is a hydrochloride salt of L-valyl ester of ganciclovir (2) that exists as a mixture of two diastereomers. According to the U.S. Food and Drug Administration specifications, the diastereomeric ratio of valganciclovir hydrochloride 1 should be maintained in the range 55:45 to 45:55. According to the U.S. Food and Drug Administration specifications, the diastereomeric ratio of valganciclovir hydrochloride 1 should be maintained in the range 55:45 to 45:55. During the process development of valganciclovir hydrochloride, six related substances (impurities) were observed along with the final active pharmaceutical ingredient. Among these six impurities, ganciclovir (2) and guanine (3) are the key starting materials and degraded impurities of ganciclovir, respectively. The remaining four impurities were identified as isovalganciclovir hydrochloride (4), methoxymethylguanine (5), O-acetoxy ganciclovir (6), and isovalarylganciclovir (7). The present work describes the synthesis and characterization of these four impurities.